CG
MRNA icon

Cutler Group’s Moderna MRNA Stock Holding History

Cutler Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-46,500
Closed -$813K – 3110
2023
Q4 		$813K Sell
46,500
-2,500
-5% -$210K 0.07% 297
2023
Q3 		$31K Buy
49,000
+24,800
+102% +$2.77M ﹤0.01% 1749
2023
Q2 		$39K Sell
24,200
-15,200
-39% -$2.03M 0.01% 1448
2023
Q1 		$247K Sell
39,400
-66,800
-63% -$11M 0.03% 594
2022
Q4 		$1.06M Buy
106,200
+14,800
+16% +$2.42M 0.09% 239
2022
Q3 		$368K Buy
91,400
+43,600
+91% +$6.62M 0.03% 674
2022
Q2 		$367K Sell
47,800
-33,100
-41% -$4.73M 0.03% 672
2022
Q1 		$901K Buy
80,900
+65,400
+422% +$11M 0.05% 420
2021
Q4 		$187K Sell
15,500
-4,800
-24% -$1.4M 0.01% 1374
2021
Q3 		$2.27M Buy
20,300
+18,600
+1,094% +$6.86M 0.1% 219
2021
Q2 		$109K Buy
1,700
+300
+21% +$53.6K 0.01% 1801
2021
Q1 		$42K Sell
1,400
-25,800
-95% -$3.74M ﹤0.01% 2538
2020
Q4 		$133K Buy
27,200
+25,500
+1,500% +$2.58M 0.01% 1335
2020
Q3 		$45K Sell
1,700
-19,300
-92% -$1.35M ﹤0.01% 1860
2020
Q2 		$113K Sell
21,000
-16,700
-44% -$915K 0.01% 1226
2020
Q1 		$114K Buy
37,700
+34,400
+1,042% +$791K 0.01% 1270
2019
Q4 		$6K Sell
3,300
-4,800
-59% -$85.2K ﹤0.01% 2943
2019
Q3 		$6K Sell
8,100
-3,900
-33% -$57.6K ﹤0.01% 2926
2019
Q2 		$5K Buy
+12,000
New +$258K ﹤0.01% 3114

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's MRNA Position: Q1 2024 in Review

Cutler Group increased its Moderna (MRNA) stake by 160% in Q1 2024, buying an estimated $8.06K and bringing the position to 130 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Cutler Group first reported a position in MRNA in Q4 2018 and has held it in 20 quarters since. The position peaked at $11.5M in Q1 2022. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Cutler Group held 130 shares of Moderna worth $13K as of Q1 2024.
  • Cutler Group bought 80 Moderna shares in Q1 2024, an estimated $8.06K.
  • Moderna made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1186 holding.
  • Cutler Group first reported a position in Moderna in Q4 2018 and has held it in 20 quarters since.
  • Cutler Group's Moderna position peaked at $11.5M in Q1 2022.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.